FAST NEWS: Innocare Pharma Loss Narrows on New Drug’s Contribution
The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday that its net loss shrank by 83.5% to 64.5 million yuan ($10.1 million) last year from 2020 levels. Looking up: The company…
RELATED ARTICLES
-
FAST NEWS: InnoCare inches closer to profitability on strong sales gains
9969.HK
-
FAST NEWS: InnoCare’s loss narrows on higher lymphoma drug sales
9969.HK
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
HBM gets health boost from drug licensing deals
2142.HK
- InSilico seeks IPO boost to get AI drugs over the line
Discover hidden China stock gems in our weekly newsletter